MeiraGTx Holdings (MGTX) Operating Leases (2018 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Operating Leases came in at $11.4 million in Q4 2025, up 50.88% YoY from $7.5 million in Q4 2024, and down 1.56% on a QoQ basis from $11.5 million in Q3 2025.
MeiraGTx Holdings (MGTX) Operating Leases (2018 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 8 years of Operating Leases data on file, last reported at $11.4 million in Q4 2025.
- Quarterly Operating Leases rose 50.88% year-over-year to $11.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.4 million (up 50.88% YoY) and the FY2025 annual result came in at $11.4 million, up 50.88% from the prior year.
- Operating Leases eased to $11.4 million in Q4 2025, from $11.5 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $22.4 million in Q2 2021 to a low of $4.0 million in Q2 2025.
- A 5-year average of $14.4 million and a median of $14.9 million in 2023 frame the typical range for Operating Leases.
- The widest YoY moves for Operating Leases: up 50.88% in 2025, down 65.36% in 2025.
- Tracing MGTX's Operating Leases over 5 years: stood at $20.4 million in 2021, then retreated by 14.87% to $17.3 million in 2022, then declined by 25.27% to $13.0 million in 2023, then plunged by 41.92% to $7.5 million in 2024, then surged by 50.88% to $11.4 million in 2025.
- The last three Operating Leases figures came in at $11.4 million (Q4 2025), $11.5 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.35 Mn |
| Sep 30, 2025 | 11.53 Mn |
| Jun 30, 2025 | 4.05 Mn |
| Mar 31, 2025 | 4.09 Mn |
| Dec 31, 2024 | 7.52 Mn |
| Sep 30, 2024 | 9.61 Mn |
| Jun 30, 2024 | 10.69 Mn |
| Mar 31, 2024 | 11.80 Mn |
| Dec 31, 2023 | 12.95 Mn |
| Sep 30, 2023 | 14.26 Mn |
| Jun 30, 2023 | 15.51 Mn |
| Mar 31, 2023 | 16.45 Mn |
| Dec 31, 2022 | 17.33 Mn |
| Sep 30, 2022 | 17.46 Mn |
| Jun 30, 2022 | 19.06 Mn |
| Mar 31, 2022 | 20.77 Mn |
| Dec 31, 2021 | 20.36 Mn |
| Sep 30, 2021 | 21.26 Mn |
| Jun 30, 2021 | 22.36 Mn |
| Mar 31, 2021 | 20.00 Mn |